Analysis of CXCL9, PD1 and PD-L1 mRNA in Stage T1 Non-Muscle Invasive Bladder Cancer and Their Association with Prognosis

SIMPLE SUMMARY: Non-muscle invasive bladder cancer (NMIBC) patients possess a high rate of recurrences and very long treatment times, which remains a major unresolved problem for them and the health care system. We analyzed the mRNA of three immune markers, CXCL9, PD1 and PD-L1, in 80 NMIBC by qRT-P...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubon, Jennifer, Sikic, Danijel, Eckstein, Markus, Weyerer, Veronika, Stöhr, Robert, Neumann, Angela, Keck, Bastian, Wullich, Bernd, Hartmann, Arndt, Wirtz, Ralph M., Taubert, Helge, Wach, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601021/
https://www.ncbi.nlm.nih.gov/pubmed/33003392
http://dx.doi.org/10.3390/cancers12102794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601021/
https://www.ncbi.nlm.nih.gov/pubmed/33003392
http://dx.doi.org/10.3390/cancers12102794

Ejemplares similares